Geographic atrophy is a subtype of advanced age-related macular degeneration (AMD ... AMD progresses through several stages, usually starting with dry AMD, which is the more common form of ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated ... hemorrhage (Figure 3). Typically, myopic CNV is ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The large economic burden from late-stage age-related macular degeneration on patients ... including nAMD and GA, in 3 countries with diverse health care systems, and different access hurdles ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Photodynamic therapy with verteporfin of CNV represents an advancement in the treatment of myopic macular degeneration complicated by CNV. The aim of PDT is to treat CNV, especially located into ...